Tuesday, December 17, 2013 6:33:27 PM
UPDATE: UTHSCSA Releases New Findings For VG Life Sciences’ Physician-IND Phase I Cancer Study
Back in April, BioNews Texas reported on positive safety results for California-based VG Life Sciences‘ Phase I study of its promising anti-cancer drug, which were conducted at The University of Texas Health Science Center in San Antonio (UTHSCSA). Since that time, continued Phase I testing of Physician-IND for tolerability and toxicity of its patented technology in patients with advanced stage solid tumors has revealed more positive results.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM